When culturing stem cells, "scale-up" can take on various meanings depending on your goals. Whether you want to increase the quantity or yield of your chosen cell type(s), move from traditional two-dimensional (2D) culture systems to three-dimensional (3D) platforms, or transition to large-scale clinical manufacturing, º£½ÇÆƽâ°æ Technologies can support you with tools, expertise, and guidance tailored to every aspect of scale-up.
Browse the resources below for insights on scaling up human pluripotent stem cells (hPSCs), immune cells, hematopoietic stem and progenitor cells (HSPCs), and other specialized cell types. Topics include maintaining characteristics like pluripotency and differentiation potential, meeting compliance regulations, optimizing cultures to achieve high yields, and adopting systems to mimic in vivo conditions for disease modeling, drug discovery, and therapeutic development.
In this self-paced, virtual course, you will learn how ancillary materials influence the safety, consistency, and scalability of cell and gene therapy manufacturing. Understanding these impacts is essential to successfully scaling up production while maintaining product quality and regulatory compliance.
